BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38400679)

  • 1. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
    Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM
    Cancer Med; 2024 Feb; 13(3):e7004. PubMed ID: 38400679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
    Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
    Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
    Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
    J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
    Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
    BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
    Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
    Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.
    Sun Y; Wang Y; Fan C; Gao P; Wang X; Wei G; Wei J
    Mol Cancer; 2014 Jun; 13():137. PubMed ID: 24889938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
    Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
    Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes.
    Althobiti M; Muftah AA; Aleskandarany MA; Joseph C; Toss MS; Green A; Rakha E
    Breast Cancer Res Treat; 2020 Aug; 182(3):581-589. PubMed ID: 32524353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
    Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
    BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
    Aleskandarany MA; Abduljabbar R; Ashankyty I; Elmouna A; Jerjees D; Ali S; Buluwela L; Diez-Rodriguez M; Caldas C; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Sep; 159(2):215-27. PubMed ID: 27514395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.
    Hou W; He W; Li Y; Ma R; Wang Z; Zhu X; Fu Q; Wen Y; Li H; Wen W
    Eur Arch Otorhinolaryngol; 2014 Jan; 271(1):171-9. PubMed ID: 23625387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
    Demir H; Dulgar O; Gulle BT; Turna H; Ilvan S
    Bosn J Basic Med Sci; 2018 Nov; 18(4):313-319. PubMed ID: 29924962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
    Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer.
    Kladi-Skandali A; Sideris DC; Scorilas A
    Clin Chem Lab Med; 2018 Dec; 57(2):276-287. PubMed ID: 30325729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients.
    Izycka N; Rucinski M; Andrzejewska M; Szubert S; Nowak-Markwitz E; Sterzynska K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
    Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
    Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
    Zhou Y; Wang Y; Ju X; Lan J; Zou H; Li S; Qi Y; Jia W; Hu J; Liang W; Zhang W; Pang L; Li F
    Biomark Med; 2015; 9(8):777-90. PubMed ID: 26230297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.